# Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma

> **NCT02004275** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Alliance for Clinical Trials in Oncology** · enrollment: 118 (actual)

## Conditions studied

- Multiple Myeloma in Relapse

## Interventions

- **DRUG:** pomalidomide
- **DRUG:** ixazomib
- **DRUG:** dexamethasone

## Key facts

- **NCT ID:** NCT02004275
- **Lead sponsor:** Alliance for Clinical Trials in Oncology
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-02
- **Primary completion:** 2021-12-01
- **Final completion:** —
- **Target enrollment:** 118 (ACTUAL)
- **Last updated:** 2023-12-01

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02004275

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02004275, "Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Relapsed Multiple Myeloma". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02004275. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*